MA28869B1 - Phenylaminothiazoles substitues, et leur utilisation - Google Patents

Phenylaminothiazoles substitues, et leur utilisation

Info

Publication number
MA28869B1
MA28869B1 MA29769A MA29769A MA28869B1 MA 28869 B1 MA28869 B1 MA 28869B1 MA 29769 A MA29769 A MA 29769A MA 29769 A MA29769 A MA 29769A MA 28869 B1 MA28869 B1 MA 28869B1
Authority
MA
Morocco
Prior art keywords
phenylaminothiazoles
substituted
substituted phenylaminothiazoles
Prior art date
Application number
MA29769A
Other languages
English (en)
Inventor
Jens-Kerim Ergueden
Gunter Karig
Ulrich Rosentreter
Barbara Albrecht
Kerstin Henninger
Joachim Huetter
Nicole Diedrichs
Peter Nell
Sabine Arndt
Walter Huebsch
Andreas Knorr
Karl-Heinz Schlemmer
Dirk Brohm
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of MA28869B1 publication Critical patent/MA28869B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29769A 2004-09-03 2007-03-23 Phenylaminothiazoles substitues, et leur utilisation MA28869B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004042607A DE102004042607A1 (de) 2004-09-03 2004-09-03 Substituierte Phenylaminothiazole und ihre Verwendung

Publications (1)

Publication Number Publication Date
MA28869B1 true MA28869B1 (fr) 2007-09-03

Family

ID=35852458

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29769A MA28869B1 (fr) 2004-09-03 2007-03-23 Phenylaminothiazoles substitues, et leur utilisation

Country Status (24)

Country Link
US (1) US8691850B2 (fr)
EP (1) EP1812430B1 (fr)
JP (1) JP4999691B2 (fr)
KR (1) KR20070057235A (fr)
CN (1) CN101056875A (fr)
AR (1) AR050551A1 (fr)
AT (1) ATE428710T1 (fr)
AU (1) AU2005281941A1 (fr)
BR (1) BRPI0514833A (fr)
CA (1) CA2578596C (fr)
DE (2) DE102004042607A1 (fr)
EC (1) ECSP077296A (fr)
ES (1) ES2324049T3 (fr)
GT (1) GT200500238A (fr)
IL (1) IL181670A0 (fr)
MA (1) MA28869B1 (fr)
MX (1) MX2007002470A (fr)
NO (1) NO20071343L (fr)
PE (1) PE20060589A1 (fr)
SV (1) SV2006002218A (fr)
TW (1) TW200621765A (fr)
UY (1) UY29099A1 (fr)
WO (1) WO2006027142A1 (fr)
ZA (1) ZA200701820B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006009813A1 (de) * 2006-03-01 2007-09-06 Bayer Healthcare Ag Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel
DE102006042143A1 (de) * 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006044696A1 (de) 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung
DE102006056739A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102006056740A1 (de) 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102007061763A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE102008008838A1 (de) 2008-02-13 2009-08-20 Bayer Healthcare Ag Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung
DE102008013587A1 (de) * 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
US8791146B2 (en) * 2008-05-29 2014-07-29 Bayer Intellectual Property Gmbh 2-alkoxy-substituted dicyanopyridines and their use
DE102008062567A1 (de) * 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) * 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2018153898A1 (fr) 2017-02-22 2018-08-30 Bayer Pharma Aktiengesellschaft Agonistes partiels sélectifs du récepteur a1 de l'adénosine en combinaison avec des antagonistes du récepteur des minéralocorticoïdes
WO2018153895A1 (fr) 2017-02-22 2018-08-30 Bayer Pharma Aktiengesellschaft Agonistes partiels sélectifs du récepteur a1 de l'adénosine en combinaison avec un inhibiteur de l'endopeptidase neutre et/ou un antagoniste du récepteur de l'angiotensine ii
WO2018153897A1 (fr) 2017-02-22 2018-08-30 Bayer Pharma Aktiengesellschaft Agonistes partiels sélectifs du récepteur a1 de l'adénosine en combinaison avec des inhibiteurs des canaux hcn
WO2018153900A1 (fr) 2017-02-22 2018-08-30 Bayer Aktiengesellschaft Agonistes partiels sélectifs du récepteur a1 de l'adénosine en combinaison avec des inhibiteurs de sglt-2
WO2018153899A1 (fr) 2017-02-22 2018-08-30 Bayer Pharma Aktiengesellschaft Agonistes partiels sélectifs du récepteur a1 de l'adénosine en combinaison avec des stimulateurs et/ou activateurs de la guanylate cyclase soluble (sgc)
JP7323913B2 (ja) * 2019-04-12 2023-08-09 国立大学法人 筑波大学 睡眠誘導剤である複素環化合物

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW299333B (fr) 1992-12-29 1997-03-01 Takeda Pharm Industry Co Ltd
EP0765327B1 (fr) 1994-06-16 1999-07-21 Pfizer Inc. Pyrazolo et pyrrolopyridines
JPH09132529A (ja) 1995-11-09 1997-05-20 Ono Pharmaceut Co Ltd 一酸化窒素合成酵素阻害剤
CZ220498A3 (cs) * 1996-01-17 1998-11-11 Novo Nordisk A/S Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
JPH10324687A (ja) 1997-02-19 1998-12-08 Nippon Soda Co Ltd ピロール化合物、製法および農園芸用殺菌剤
US6191280B1 (en) * 1997-05-30 2001-02-20 Basf Aktiengesellschaft Method for producing substituted thiopyridines
EP1000066A1 (fr) 1997-07-16 2000-05-17 Novo Nordisk A/S Derives de 1,2,4-thiadiazine fusionnee, leur preparation et utilisation
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
DE19834044A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19834047A1 (de) * 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) * 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) * 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19947154A1 (de) * 1999-10-01 2001-10-04 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
ATE293962T1 (de) * 2000-02-25 2005-05-15 Hoffmann La Roche Adenosin-rezeptor modulatoren
KR20030026979A (ko) * 2000-07-18 2003-04-03 야마노우치세이야쿠 가부시키가이샤 디시아노피리딘 유도체를 포함하는 의약
AR031176A1 (es) * 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
JP2004515543A (ja) 2000-12-11 2004-05-27 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 有害無脊椎動物を防除するためのキナゾリノン類およびピリジニルピリミジノン類
AU3113902A (en) 2000-12-21 2002-07-01 Bristol Myers Squibb Co Thiazolyl inhibitors of tec family tyrosine kinases
DE10110438A1 (de) * 2001-03-05 2002-09-19 Bayer Ag Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10110747A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
DE10110749A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10110754A1 (de) * 2001-03-07 2002-09-19 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10115922A1 (de) * 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10115945A1 (de) * 2001-03-30 2002-10-02 Bayer Ag Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10134481A1 (de) * 2001-07-16 2003-01-30 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
DE10238113A1 (de) * 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
JP2003183254A (ja) 2001-12-20 2003-07-03 Yamanouchi Pharmaceut Co Ltd ２−アシルアミノ−３，５−ジシアノピリジン誘導体又はその塩
AU2003237121A1 (en) 2002-04-26 2003-11-10 Vertex Pharmaceuticals Incorporated Pyrrole derivatives as inhibitors of erk2 and uses thereof
DE10220570A1 (de) * 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
EP1388342A1 (fr) 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Dérivés de cycloalkenylamine condensé avec un hététoaryle et acylé et leur utilisation comme produits pharmaceutiques
MXPA05001688A (es) * 2002-08-12 2005-04-19 Sugen Inc 3-pirrolil-piridopirazoles y 3-pirrolil-indazoles como inhibidores de cinasa novedosos.
MXPA05006367A (es) 2002-12-12 2005-08-29 Pharmacia Corp Metodo de uso de compuestos de aminocianopiridina como inhibidores de cinasa-2 de proteina activada de cinasa de proteina activada por mitogeno.
TWI270549B (en) * 2002-12-26 2007-01-11 Taisho Pharmaceutical Co Ltd Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2539707C (fr) * 2003-09-23 2011-08-09 Merck & Co., Inc. Inhibiteurs des canaux potassiques a la quinoleine
EP1687004A4 (fr) * 2003-11-10 2009-04-08 Synta Pharmaceuticals Corp Composes pyridiniques
US20050182105A1 (en) * 2004-02-04 2005-08-18 Nirschl Alexandra A. Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
JP2007161585A (ja) * 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
DE102004032651A1 (de) * 2004-07-06 2006-02-16 Bayer Healthcare Ag Verwendung von substituierten 2-Thio-3,5-dicyano-4-phenyl-6-aminopyriden bei der Behandlung von Übelkeit und Erbrechen
DE102006042143A1 (de) 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056739A1 (de) 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102006056740A1 (de) 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102008013587A1 (de) 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
DE102008062567A1 (de) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs

Also Published As

Publication number Publication date
SV2006002218A (es) 2006-10-04
US8691850B2 (en) 2014-04-08
WO2006027142A1 (fr) 2006-03-16
DE502005007106D1 (de) 2009-05-28
IL181670A0 (en) 2007-07-04
AU2005281941A1 (en) 2006-03-16
ECSP077296A (es) 2007-04-26
PE20060589A1 (es) 2006-08-12
JP2008511614A (ja) 2008-04-17
NO20071343L (no) 2007-05-30
CA2578596A1 (fr) 2006-03-16
KR20070057235A (ko) 2007-06-04
ATE428710T1 (de) 2009-05-15
EP1812430B1 (fr) 2009-04-15
ES2324049T3 (es) 2009-07-29
EP1812430A1 (fr) 2007-08-01
UY29099A1 (es) 2006-04-28
BRPI0514833A (pt) 2008-06-24
GT200500238A (es) 2006-04-10
CA2578596C (fr) 2012-10-23
DE102004042607A1 (de) 2006-03-09
TW200621765A (en) 2006-07-01
AR050551A1 (es) 2006-11-01
CN101056875A (zh) 2007-10-17
MX2007002470A (es) 2009-02-12
JP4999691B2 (ja) 2012-08-15
US20080269300A1 (en) 2008-10-30
ZA200701820B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
EP1731506A4 (fr) Derives de 5-hydroxyindol-3-carboxylate et leur utilisation
EP1954140A4 (fr) Cetals de glycerol-levulinate et utilisation
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
EP1679966A4 (fr) Benzimidazole-, benztriazole- et benzimidazolone-o-glucosides substitues
EP2124550A4 (fr) Oxabicycloheptanes et oxabicycloheptènes, leur préparation et leur utilisation
DE602004032238D1 (de) Kombinations-batterie
MA29012B1 (fr) N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues
EP1741732A4 (fr) Copolymère polymonochlorotrifluoré
EP1683788A4 (fr) Derives de pyridone, et utilisation correspondante
EP1971600A4 (fr) Derives d'isoxasole et leur utilisation
EP1826209A4 (fr) Derives de nitromethylene et leur utilisation
DE602005021959D1 (de) Substituierte diazaspiroä4.5üdecanderivate und der
EP1731547A4 (fr) Composés polymérisables et utilisation de ceux-ci
NO20041374D0 (no) Bolgekraftverk.
DE502005004034D1 (de) Kämmmaschine.
MA28348A1 (fr) Pipéridinylcarbonyl-pyrrolidines et leur utilisation comme agonistes de mélanocortine
MA28859B1 (fr) Hexadecasaccharides biotinyles, leur preparation et leur utilisation
DE602004007958D1 (de) Inhaltsverwaltungsvorrichtung
EP1897866A4 (fr) P-trifluoromethylephenylethers substitues, leur preparation et leur utilisation
FR2878851B1 (fr) Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
EP1818347A4 (fr) Composite de polyurethanne, sa preparation et son utilisation
FI20045182A0 (fi) Tiedonsiirto UMTS järjestelmässä
EP1742904A4 (fr) Enaminones substitues, leurs derives et leur utilisation
DE602005020457D1 (de) Master-slave-flip-flop, trigger-flip-flop und zähler
EP1786431A4 (fr) Preparations de photosensibiliseur ameliorees et utilisation de celles-ci